Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II TrialYan Zhao, Jianzhong Zhang, Liming Wu et al.|Dermatology and Therapy|2025Cited by 2